CLINICAL SPECTRUM

Published on 10/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1730 times

CHAPTER 50 CLINICAL SPECTRUM

The clinical spectrum of epilepsy is vast. In terms of symptomatology, the expression of epileptic seizures is very diverse and depends on the function of the part of the brain that is involved by the abnormal neuronal discharge. The age of the affected individual at disease onset and during its evolution ranges from neonates to elderly persons, leading to multiple clinical scenarios. Certain epileptic disorders that occur early in life may have severe consequences on the developing brain. Another key determinant of epileptic diseases is the etiological background, which may include genetic factors, acquired brain lesions, or progressive brain dysfunction but may also remain unknown. This diversity and sometimes complexity are well reflected by the classifications—classification of epileptic seizures on the one hand and classification of epilepsies and epileptic syndromes on the other. All of these parameters should be analyzed by a clinician in a syndromic approach to the patient’s condition. This type of approach facilitates development of a rational management strategy, with selection of the most appropriate drugs as a function of their spectrum of efficacy, and establishes a reasonably reliable prognosis. The severity of the different epileptic syndromes varies from very benign and transient conditions to devastating diseases.

DEFINITIONS AND EPIDEMIOLOGY

Any epidemiological approach requires solid definitions of the events and conditions that are under study. Consensual agreement on even the definition of the terms seizure and epilepsy has proved difficult.

Epileptic seizures are pleomorphic, although usually stereotyped for a given individual. Unlike most neurological disorders, the majority of patients with epileptic seizures do not have permanent physical signs and can be diagnosed only by taking a history or by the chance observation of a seizure. Diagnosis is a discretionary judgment that may vary depending on the skill and experience of clinicians and the quality of available information from witnesses. Electroencephalographic and other complementary investigations are useful in classifying epilepsy but are of limited help in making the diagnosis. Some patients with seizures may never seek medical attention because they ignore or misinterpret their symptoms, or indeed they may be unaware of them. In practice, both false-positive and false-negative diagnoses are common.

The definitions of epilepsy have often included the notion of unprovoked seizures and of recurrence. Epileptic seizures may occur as a result of a variety of acute brain insults or metabolic disorders. Those seizures triggered by clear precipitants are termed “acute symptomatic seizures” but, despite exhibiting clear epileptiform phenomenology, they are not classified as epilepsy. The distinction between provoked and unprovoked seizures, however, is not always clear-cut or reliable for epilepsy diagnosis. Indeed, precipitating factors such as lack of sleep or alcohol may facilitate seizures in well-established epileptic diseases.

The notion of recurrence, which theoretically implies at least two seizures, is not a necessary characteristic for epilepsy diagnosis. The occurrence of one seizure may be sufficient when clinical or paraclinical elements suggest that there is an enduring alteration in the brain that increases the likelihood of future seizures. More than recurrence, it is the potential for recurrence of seizures that defines epilepsy. All of these distinctions and evolving concepts increase the difficulty of diagnostic accuracy and case ascertainment necessary for the accurate study of epilepsy epidemiology.

The overall annual incidence of epilepsy is generally believed to be around 50 per 100 000 (range, 40 to 70 per 100 000/year) in industrialized countries, but socioeconomically deprived people are at greater risk. First seizures are estimated to be around 70 per 100 000 annually. There is a mild predominance in males. The specific incidence as a function of age shows a bimodal curve, with two peaks, one in childhood, with figures of more than 100 per 100,000 during the first year of life, although there is evidence of a decrease in childhood incidence in recent decades. A second peak is observed in elderly people with an estimate of 150 per 100,000 over the age of 80 years, which is attributed to the many prevalent causes of brain damage at that age, with cardiovascular diseases being the most frequent (Fig. 50-1).

In terms of prevalence, several studies conducted in different regions of the world have suggested that epilepsy affects 5 to 8 per 1000 population. These estimates are based on individuals with active epilepsy, defined as patients with a seizure in the previous 5 years or still receiving antiepileptic drug treatment.

When isolated seizures are included, the cumulative risk or incidence, which measures the lifetime risk of having a nonfebrile seizure, is very high, ranging from 2% to 8% between 40 and 80 years of age.

From the difference between incidence and prevalence of active epilepsy, it is apparent that most patients with epilepsy cease to have seizures or die. It is also likely that the condition remits in many patients. However, epilepsy is associated with increased mortality, particularly but not exclusively in patients with brain lesions.

CLINICAL APPROACH TO EPILEPTIC DISORDERS

The clinical approach should consist of a description of the ictal semiology, using as far as possible a standardized terminology. A description of the ictal event(s) should be carefully obtained from the patient and relatives without reference to etiology, anatomy, or mechanisms. Detailed descriptions of the onset and evolution of focal ictal phenomena are not always necessary to make a diagnosis of partial seizure, but they are useful in patients who are candidates for surgical treatment or for research designed to elucidate the anatomical substrates or pathophysiological mechanisms underlying specific clinical behaviors. Electroencephalographic video monitoring, including direct interaction with the patient during an event, is the investigation that permits the most accurate and detailed analysis of symptoms.

The next step is to characterize the epileptic seizure type relative to the list of different types defined by the International Classification of Seizures (Table 50-1). It is essential to identify or rule out seizure types by detailed questioning of patients and relatives. Localization within the brain should be specified when this is appropriate; in the case of reflex or provoked seizures, the specific stimulus should also be specified. Electroencephalographic data are often incorporated at this stage of the diagnostic process, as many seizures are also associated with specific electroclinical characteristics. Age at onset is also a critical piece of information. Certain specific seizure types may by themselves be more or less indicative of diagnostic entities with etiological, therapeutic, and/or prognostic implications.

TABLE 50-1 International Classification of Seizures (1981)

A syndromic diagnosis should then be made whenever possible, again using the common terms proscribed by the International Classification of Epilepsies and Epileptic Syndromes. This syndromic diagnosis relies on the grouping of information: on seizure type or types, pattern of recurrence or frequency, age at onset, personal and familial antecedents, natural history, and other neurological and extraneurological manifestations. The electroencephalographic data, both interictal and sometimes ictal, are essential, as is a brain imaging examination. Magnetic resonance imaging is indicated in the majority of situations but can be omitted when certitude is reached about the diagnosis of an idiopathic generalized syndrome.

Clinical and paraclinical investigations can also help to identify specific etiologies. The etiology can consist of a specific disease frequently associated with epileptic seizures or syndromes, a genetic defect, or a specific pathological substrate, for instance, for the symptomatic focal epilepsies.

Finally, it is essential to evaluate the degree of impairment caused by the epileptic condition and to try to establish a prognosis in parallel to making decisions about the therapeutic measures to be exhibited. These steps are strongly influenced by analysis of seizure type and the syndromic diagnosis.

EPILEPTIC SEIZURES

Three great categories have been identified—generalized, partial or focal seizures, and unclassified seizures. Here they are described as individual events, with a well-defined temporal course from onset to termination. Almost every type of seizure can occur continuously or repetitively, thus constituting status epilepticus. In this case, some of the seizure characteristics may become less readily identifiable.

Generalized Seizures

In generalized seizures, the paroxysmal discharge involves both hemispheres simultaneously and in a diffuse manner. Clinical manifestations are usually bilateral and symmetrical. The electroencephalographic correlates consist of spikes, polyspikes, spikes and waves, or polyspikes and waves that are typically bilateral, synchronous, and symmetrical in the two hemispheres.

Partial Seizures

Partial seizures are very polymorphic, they reflect the function of the brain area where they take origin—the focus or the epileptogenic zone and of the pattern of spread of epileptic activity. They are, however, remarkably stereotyped in individual patients. The first clinical symptoms of a seizure have strong localizing value. When they are perceived by the patient, they define the aura. A postictal deficit can be observed, resulting from acute dysfunction of some brain areas that have been involved by the epileptic discharge. A postictal deficit may be motor, a hemianopsia, or an aphasia. Clinically, these are generally of good lateralizing value.

Interictal and ictal scalp electroencephalographic abnormalities may correlate more or less with the brain areas invaded by the discharge, but they can be difficult to detect when epileptic neuronal activity remains confined within small or deep brain areas. Intracerebral recordings with stereotaxically implanted electrodes performed in candidates for surgical treatment have contributed considerably to an understanding of anatomical-clinical correlations in partial seizures.

The terminology of simple partial seizure is used when the patient remains conscious, whereas complex partial is used when some degree of altered consciousness can be identified. The latter generally implies that larger or bilateral brain areas are involved by the ictal discharge. In the absence of video-electroencephalographic monitoring and direct interaction with the patient during a seizure, it is not always possible to ascertain the presence or absence of brief, partial alterations of consciousness. Although the dichotomy of simple versus complex may be useful in terms of appreciating seizure severity, its significance otherwise is questionable. Recent classifications give priority to associated features.

Simple Partial Seizures

EPILEPSIES AND EPILEPTIC SYNDROMES

A classification system is extremely useful from many points of view—the determination of diagnosis criteria, the elaboration of a strategy for organizing complementary investigations, the rationalization of therapeutic options based on the efficacy profile of the different drugs, the establishment of a prognosis, and the facilitation of clinical research.

The international classification (Table 50-2) may give the impression that it is simply a very long list of diseases, without providing the reader with some essential organizing notions like frequency or severity. Some syndromes are very frequent, whereas others correspond to orphan diseases, emphasizing an extraordinarily vast and diversified spectrum.

TABLE 50-2 International Classification of Epilepsies and Epileptic Syndromes

* Many metabolic or degenerative etiologies are possible. The progressive myoclonic epilepsies like Lafora and Unverricht-Lundborg diseases are classified here.

The current international classification is based on two main axes, or dichotomies. The first axis refers to the notion of partial versus generalized syndromes. In generalized epilepsies, all of the seizures are generalized seizures; the electroencephalographic characteristics are bilaterality, diffuseness, and symmetry. In partial or focal epilepsies, seizures take their origin in a focal or an epileptic zone, regardless of the fact that some seizures may become secondarily generalized. However, the term focal does not mean the epileptogenic region is a small, well-delineated focus of neuronal pathology. Focal seizures and syndromes are often due to diffuse and at times widespread areas of cerebral dysfunction. Furthermore, for several syndromes, it is unclear whether they are focal or generalized. In fact, there is a variety of conditions giving rise to a range of focal through generalized epilepsies that include diffuse hemispheric abnormalities, multifocal abnormalities, and bilaterally symmetrical localized abnormalities. Although concepts of partial and generalized epileptogenicity have value, perhaps more with respect to ictal events than to syndromes, it may not be appropriate or even useful to attempt to classify all seizures and syndromes within one or the other of these categories.

The second axis opposes the notions of idiopathic versus symptomatic. In idiopathic epilepsies, there is no brain lesion and the main etiological factor is a genetic predisposition that is identified or presumed. Symptomatic epilepsies result from structural changes in the brain, whether fixed abnormalities (scar, malformation of the cortex) or evolving damage (metabolic or degenerative disease). Brain imaging (MRI) or biological markers show the pathological context. Electroencephalographic background activity may also indicate focal regions of brain dysfunction. The term cryptogenic (presumed symptomatic) was introduced to qualify symptomatic epilepsies for which structural changes are presumed to exist but cannot be identified by current investigations. The use of brain MRI has reduced considerably the number of cryptogenic varieties by permitting the identification of hippocampal sclerosis and a variety of other malformations of the cerebral cortex.

The classification should be regarded as an evolving one. Progress in genetics and brain imaging is having a major impact on different concepts of epileptogenesis. Indeed, the rapidly moving field of genetics has contributed greatly to a better understanding of some epileptic disorders. But the relationship between genetic variations or mutations and phenotypic expression remains complicated. Because a single, relatively well-defined, idiopathic epilepsy syndrome can be due to more than one genetic abnormality and because members of a family sharing a common genetic abnormality can present with different epilepsy syndromes, it is premature to attempt a classification of epilepsy syndromes solely on the basis of specific genetic etiologies.

Mesial Temporal Lobe Epilepsy: A Surgically Remediable Syndrome

The temporal lobe is a vast lobe of the brain with distinct regions: a pole, a lateral aspect including peri-sylvian areas, and mesial structures including the amygdala, the hippocampal formations, and associated limbic cortices. Temporal lobe epilepsy may be caused by different etiologies—tumor, vascular malformations, or cortical dysplasias. However, in almost 50% of cases, hippocampal sclerosis is the major pathological substrate and is implicated in seizure generation, leading to the concept of mesial temporal lobe epilepsy. Patients have frequent antecedents of febrile seizures, often prolonged (complex febrile seizures). The onset of afebrile seizures occurs after a latency period of several years. The first manifestations can be subtle simple partial seizures (auras) with autonomic or psychic symptoms that may be unrecognized until the first secondarily generalized seizure.

The clinical features of partial seizures include an aura, often epigastric, with autonomic or psychic symptoms followed by an alteration of consciousness, an arrest or staring reaction, oroalimentary automatisms, gestural automatisms, and limb dystonia; a postictal dysphasia may be present if the dominant hemisphere is implicated. Electroencephalography shows a temporal lobe interictal and ictal focus. The presence of hippocampal sclerosis, detectable by MRI, is strongly suggestive when the picture is not typical. Medical intractability is frequent, as is memory impairment. The surgical prognosis is good overall. However, mesial temporal lobe epilepsy is not a model of pure focal epilepsy; it is more of a regional disease.

Generalized Epilepsy With Febrile Seizure Plus: Familial Versus Conventional Epileptic Syndromes

The concept of generalized epilepsy with febrile seizures plus was introduced by Scheffer and Berkovic to describe families in which febrile seizures coexist with epilepsy. In this heterogeneous familial context, some affected members exhibit a particular febrile seizure, termed febrile seizures plus, because the fits persist beyond the classic limit of 6 years of age. On the other hand, other family members may have typical febrile seizures, which disappear before the age of 6. Moreover, varying types of afebrile seizure are observed in affected individuals, most often generalized seizures, tonic-clonic, absences, atonic, tonic, and myoclonic seizures. Absence seizures are often atypical, with a longer duration and lower frequency than in typical childhood absence epilepsy. Electroencephalographic abnormalities usually consist of diffuse spike-wave patterns and photosensitivity may be present. Afebrile seizures may begin during childhood in association with the febrile seizures; this continuum between febrile and afebrile seizures is typical of the concept of generalized epilepsy with febrile seizures plus syndrome. Afebrile seizures may also appear after a seizure-free period or in subjects without a previous febrile seizure history. Seizures may cease around the age of 10 to 12 years, whereas in other patients seizures are persistent and difficult to treat. Hemiconvulsive, temporal, and frontal lobe seizures have, however, also been reported, extending the concept of generalized epilepsy with febrile seizures plus spectrum to partial seizures and further increasing its phenotypic diversity. This familial syndrome, which differs from conventional epileptic syndromes, has proved to be extremely fertile in terms of genetic characterization, and several ion channel genes, SCN1B, SCN1A, and GABRG2, have been implicated so far.

PROGNOSIS: FROM BENIGN CONDITIONS TO DEVASTATING DISEASES

The evaluation of the prognosis and an appreciation of the degree of impairment caused by the epileptic condition are essential and should be based on both the nature of the syndrome and the characteristics of individual patients.

After a first unprovoked seizure, the overall risk of relapse at 2 years ranges from 25% to 52%, with a median of 38%. In newly diagnosed epilepsy, the overall prognosis for full seizure control is very good, with more than 70% of patients achieving long-term remission, the majority within 5 years of diagnosis.

Beyond these global estimates of prognosis, more precise information concerning outcome for a given individual should be based on a syndromic approach. The prognosis of the idiopathic generalized epilepsies is generally good. In absence epilepsies, the absence seizures are easily controlled by drug treatment and disappear in most of the patients during adolescence. Some generalized tonic-clonic events are possible later on. However, a late onset (juvenile absence epilepsy) or the presence of eyelid or perioral myoclonus indicates a higher risk of seizure persistence and necessitates longer treatment. In juvenile myoclonic epilepsy, the response to treatment is usually very good, but relapses occur in 90% of cases if treatment is discontinued.

Epileptic encephalopathies carry a poor prognosis. Psychomotor development is impaired, and personality or psychiatric disorders are often present. Treatments are rarely efficacious, or only in a transitory manner, even with polytherapy. Cyclical periods of seizure aggravation occur with falls and injuries and sometimes with status epilepticus. Iatrogenic complications are frequent, with global slowing, somnolence, ataxia, and deterioration of cognitive impairment.

The prognosis of symptomatic partial epilepsies is highly variable. The risk of pharmacoresistance to antiepileptic drugs is relatively high. This risk is influenced by the nature of the underlying brain lesion. For instance, the probability of being seizure free for a year with treatment is 50% to 60% in the case of poststroke epilepsy, whereas it decreases to 10% to 20% in cases of malformation of the cerebral cortex or of hippocampal sclerosis.

People with epilepsy, despite an overall good prognosis for seizure control, have a greater risk of death compared with those without epilepsy. This increased risk is most evident in people with chronic epilepsy, particularly the young, and those with symptomatic epilepsy. Trauma, suicide, pneumonia, status epilepticus, and seizures cause death in people with epilepsy more frequently than in the general population. Sudden unexpected death in epilepsy is increasingly recognized, especially in persons with severe epilepsy. The mechanism of sudden unexpected death in epilepsy is unknown. Suggestions have been made that substandard care may contribute to the risk, but this theory needs to be formally investigated.